4.4 Review

China Consensus Document on Allergy Diagnostics

期刊

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH
卷 13, 期 2, 页码 177-205

出版社

KOREAN ACAD ASTHMA ALLERGY & CLINICAL IMMUNOLOGY
DOI: 10.4168/aair.2021.13.2.177

关键词

Allergen; diagnosis; consensus; China

资金

  1. [SZYJTD201806]

向作者/读者索取更多资源

The prevalence of allergic diseases has been increasing in China in recent years, with allergen identification being key to diagnosis. While various allergy diagnostic methods are available, they are not standardized, making diagnostics more complex due to cross-sensitization and co-sensitization. This consensus aims to standardize allergen diagnostic methods and provide guidance for healthcare professionals, and was prepared by a panel of experts from professional allergy associations in China.
The prevalence of allergic diseases has increased dramatically in recent years in China, affecting the quality of life in 40% of the population. The identification of allergens is the key to the diagnosis of allergic diseases. Presently, several methods of allergy diagnostics are available in China, but they have not been standardized. Additionally, cross-sensitization and co-sensitization make allergy diagnostics even more complicated. Based on 4 aspects of allergic disease (mechanism, diagnosis procedures, allergen detection in vivo and in vitro as well as the distribution map of the most important airborne allergens in China) and by referring to the consensus of the European Society of Allergy and Clinical Immunology, the World Allergy Organization, and the important literature on allergy diagnostics in China in recent years, we drafted this consensus of allergy diagnostics with Chinese characteristics. It aims to standardize the diagnostic methods of allergens and provides a reference for health care givers. The current document was prepared by a panel of experts from the main stream of professional allergy associations in China.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据